Page last updated: 2024-10-21

sk&f 82958 and Hyperactivity, Motor

sk&f 82958 has been researched along with Hyperactivity, Motor in 4 studies

Research Excerpts

ExcerptRelevanceReference
"Ritanserin pretreatment blunted systemic SKF 82958-induced hyperlocomotion and returned intrastriatal D1-mediated hyperactivity to sham lesion levels."1.32Intrastriatal serotonin 5-HT2 receptors mediate dopamine D1-induced hyperlocomotion in 6-hydroxydopamine-lesioned rats. ( Bishop, C; Kamdar, DP; Walker, PD, 2003)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sørensen, G1
Reddy, IA1
Weikop, P1
Graham, DL1
Stanwood, GD1
Wortwein, G1
Galli, A1
Fink-Jensen, A1
Miller, JS1
Tallarida, RJ1
Unterwald, EM1
Bishop, C1
Kamdar, DP1
Walker, PD1
Cohen, C1
Perrault, G1
Sanger, DJ1

Other Studies

4 other studies available for sk&f 82958 and Hyperactivity, Motor

ArticleYear
The glucagon-like peptide 1 (GLP-1) receptor agonist exendin-4 reduces cocaine self-administration in mice.
    Physiology & behavior, 2015, Oct-01, Volume: 149

    Topics: Analysis of Variance; Animals; Benzazepines; Cocaine; Corpus Striatum; Dopamine; Dopamine Agonists;

2015
Inhibition of GSK3 attenuates dopamine D1 receptor agonist-induced hyperactivity in mice.
    Brain research bulletin, 2010, May-31, Volume: 82, Issue:3-4

    Topics: Animals; Behavior, Animal; Benzazepines; Dopamine Agonists; Dose-Response Relationship, Drug; Glycog

2010
Intrastriatal serotonin 5-HT2 receptors mediate dopamine D1-induced hyperlocomotion in 6-hydroxydopamine-lesioned rats.
    Synapse (New York, N.Y.), 2003, Volume: 50, Issue:2

    Topics: Animals; Benzazepines; Denervation; Dopamine; Dopamine Agonists; Drug Interactions; Dyskinesia, Drug

2003
Effects of D1 dopamine receptor agonists on oral ethanol self-administration in rats: comparison with their efficacy to produce grooming and hyperactivity.
    Psychopharmacology, 1999, Volume: 142, Issue:1

    Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Administration, Oral; Alcohol Drinking;

1999